XML 108 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 10 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Cash Flows from Operating Activities:        
Net income (loss) $ 143,504 $ (17,984) $ (66,302) $ 1,308,097
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Interest income earned on investments held in Trust Account (785,928) (21,058) (2,258,904)
Changes in fair value of warrant liabilities (2,040) (53,500)
Changes in operating assets and liabilities:        
Other current assets (1,698) (66,950)
Due to a related party 30,000 90,000
Accrued expenses and other payable 287,073 (61,065) 14,208 330,486
Net cash used in operating activities (329,089) (100,107) (52,094) (650,771)
Cash Flows from Investing Activities:        
Purchase of investments held in Trust Account (58,506,250) (58,506,250)
Net cash used in investing activities (58,506,250) (58,506,250)
Cash Flows from Financing Activities:        
Proceeds from sale of public units in Public Offering 57,500,000 57,500,000
Proceeds from sale of private placement units 3,431,250 3,431,250
Proceeds from related parties 85,340 295,000 85,340
Repayment of promissory note to a related party     (380,340)
Payment of underwriting commission (1,150,000) (1,150,000)
Capital contribution from the Sponsor     25,000 57,500,000
Payment of offering costs (326,355) (234,428) (326,355)
Deposits received from a target company for business combination     330,969
Net cash provided by financing activities 59,540,235 85,572 59,490,864
Net change in cash (329,089) 933,878 33,478 333,843
Cash at beginning of period 367,321 33,478 33,478
Cash at end of period 38,232 967,356 33,478 367,321
Supplemental disclosure of non-cash financing activities:        
Initial classification of common stock subject to redemption 51,579,480    
Initial classification of derivative warrant liabilities – private warrant 62,400    
Deferred underwriting’ commission fees payable 2,012,500 2,012,500
Offering costs paid by the Sponsor on behalf of the Company 68,743    
Accretion of carrying value to redemption value of redeemable ordinary shares $ 2,553,357 $ 89,802 $ 7,418,245